Cardiovascular disease, type 2 diabetes, joint deterioration, sleep apnea, and multiple cancer risks are all associated with excess weight
The ratio of ruthenium released from the nanoparticles was calculated as the percentage of cumulative ruthenium in the dialysate relative to the total amount of ruthenium present in the nanoparticles
Specific criteria vary based on individual circumstances and medical guidelines
Recent evidence highlights the direct and indirect anti-inflammatory properties of GLP-1, suggesting a potential additional therapeutic strategy for patients with inflammatory bowel disease (IBD)
Previously, a Phase 2 randomized trial of an older, less potent GLP-1 drug, Liraglutide in 200 participants, was presented at the 2024 Alzheimers Association annual conference but has not yet been published